EMA
safety_alert
· 2025-03-13
Unregulated advanced therapy medicinal products pose serious risks to health
Summary
EMA warns that unregulated advanced therapy medicinal products pose serious health risks in the EU, including dendritic cell–based cancer therapies and other AT…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Authorities warn about unregulated products in the EU, including dendritic cell cancer therapies